PsyIndex Weekly Update – June 21, 2021 – June 25, 2021

PsyIndex Weekly Update

June 21, 2021 – June 25, 2021
The PsyIndex extended its losses last week, although there were signs of a rebound toward the end of the week. With a combination of new public listings and favorable regulatory developments, the industry has a number of upcoming catalysts that investors will be watching closely.

Market Performance

Weekly Performance: $129.39 (-3.64%)

Powered by

CFN Enterprises Inc. (OTCQB: CNFN)

Top Gainers

Top Decliners

View All Index Constituents

Corporate News, Deals & Listings

  • Filament Health Corp. announced it has received final approval to list its common shares on the NEO and began trading on June 24, 2021 under the symbol NEO: FH. Press Release
  • Field Trip Health Ltd. (TSX: FTRP) announced its fiscal fourth-quarter financial results, as the largest vertically integrated psychedelics company. Press Release
  • Silo Wellness Inc. (CSE: SILO) announced the launch of Marley One, the first global functional and psychedelic mushroom consumer brand, in collaboration with the family of legendary musician Bob Marley. Press Release
  • Revive Therapeutics Inc. (CSE: RVV) announced that its shares were approved to list on the OTCQB. Press Release
Read More

Featured Content

 

Industry Developments

  • The future of psychedelic medicine might skip the trip. via Forbes
  • A new psychedelics ETF just launched: Here’s why that’s big news. via Motley Fool
  • California State Senate passes psychedelic legislation in latest wave. via Mondaq
Visit the PsyIndex

Primary Sponsor


Karma Koala Podcast

Top Marijuana Blog